Prevention of group B Streptococcus infection in neonates

Annals of Pharmacotherapy

Volumn 31, Issue 7-8, 1997, Pages 897-906

  Logsdon, Beth A ^a   Casto, Daniel T ^b,c  

^a Cook Children's Medical Center ^*  (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Group B Streptococcus; Neonates; Prophylaxis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; ERYTHROMYCIN; PENICILLIN G; PENICILLIN V POTASSIUM;

ACTIVE IMMUNIZATION; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; IMMUNOPROPHYLAXIS; MORBIDITY; MORTALITY; NEWBORN INFECTION; PASSIVE IMMUNIZATION; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0030843207     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100718     Document Type: Article

References (68)

1. Katz VL. Management of group B streptococcal disease in pregnancy. Clin Obstet Gynecol 1993;36:832-42.
2. Platt MW, Gilson GJ. Group B streptococcal disease in the perinatal period. Am Fam Physician l994;49:434-42.
3. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington J, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1995:980-1054.
4. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992;41:25-32.
5. Noya FJ, Baker CJ. Prevention of group B streptococcal infection. Infect Dis Clin North Am 1992;6:41-55.
6. Baker CJ. Summary of the workshop on perinatal infections due to group B Streptococcus. J Infect Dis 1977;136:137-52.
7. Erikson NL, Blanco JD. Group B streptococcal infection in pregnancy. Semin Perinatol 1993;17:432-42.
8. Fletcher JL, Gordon RC. Perinatal transmission of bacterial sexually transmitted diseases. J Fam Pract 1990;30:689-96.
9. Regan JA, Kubanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991;77:604-10.
10. Anthony BF, Eisenstadt RT, Carter J, Kim KS, Hobel CJ. Genital and intestinal carriage of group B streptococci during pregnancy. J Infect Dis 1981;143:761-6.
11. Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol 1979; 135:1062-5.
12. Dillon HC, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B Streptococcus during pregnancy. J Infect Dis 1982;145:794-9.
13. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983;148: 802-9.
14. Badri MS, Zawaneh S, Cruz AC, Mantilla G, Baer H, Spellacy WN, et al. Rectal colonization with group B Streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis 1977;135:308-12.
15. Baker CJ, Goroff DK, Alpert S, Crockett VA, Zinner SH, Evrard JR, et al. Vaginal colonization with group B Streptococcus: a study of college women. J Infect Dis 1977;135:392-7.
16. Ferrieri P, Blair LL. Pharyngeal carriage of group B Streptococcus: detection by three methods. J Clin Microbiol 1977;6:136-9.
17. Matorras R, Garcia-Perea A, Usandizaga JA, Omenaca F. Recto-vaginal colonization and urinary tract infection by group B Streptococcus in the pregnant diabetic patient. Acta Obstet Scand 1988;67:617-20.
18. Minkoff H, Mead P. An obstetric approach to prevention of early-onset group B streptococcal sepsis. Am J Obstet Gynecol 1986;54:973-7.
19. Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 1985;35:267-80.
20. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.
21. Schuchat A, Denver-Robinson K, Plikaytis BD, Zangwill K, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623-9.
22. Pass MA, Gray BM, Khare S, Dillon HC. Prospective studies of group B streptococcal infections in infants. J Pediatr l979;95:431-3.
23. Wood EG, Dillon HC. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol 1981;140:515-20.
24. Moller M, Thomsen AC, Borch K, Dinesen K, Zdravkovic M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984;11:69-70.
25. Liston TE, Harris RE, Foshee S, Null DM. Relationship of neonatal pneumonia to maternal urinary and neonatal isolates of group B streptococci. South Med J 1979;72:1410-2.
26. Persson K, Christensen KK, Christensen P, Forsgren A, Jorgensen C, Persson P. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis 1985;17:195-9.
27. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6.
28. Pass MA, Khare S, Dillon HC. Twin pregnancies: incidence of group B streptococcal colonization and disease. J Pediatr 1980;97:635-7.
29. Cochi SL, Feldman RA. Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight. Pediatr Infect Dis J 1983;2:414-5.
30. Hueston WJ. Preventing group B streptococcal infection in newborns. Am Fam Physician 1991;43:487-92.
31. Merenstein GB, Todd WA, Brown G, Yost CC, Luzier T. Group B β-hemolytic Streptococcus; randomized controlled treatment study at term. Obstet Gynecol 1980;55:315-8.
32. Lewin EB, Amstey MS. Natural history of group B Streptococcus colonization and its therapy during pregnancy. Am J Obstet Gynecol 1981; 139:512-5.
33. Morales WJ, Lim DV, Walsk AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986;155:979-83.
34. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
35. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B Streptococcus. JAMA 1979;241:1245-7.
36. Allardice JG, Baskett TF, Sesha MMK, Bowman N, Malazarewicz R. Perinatal group B streptococcal colonization and infection. Am J Obstet Gynecol 1982;142:617-20.
37. Morales WJ, Lim DV. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987;157:13-6.
38. Easmon CSF, Hastings MJ, Deeley J, Bloxham B, Rivers RP, Marwood R. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. Br J Obstet Gynaecol 1983;90:633-5.
39. Matorras R, Garcia-Perea A, Omenaca F, Diez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol 1991;40:57-62.
40. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73:583-7.
41. Silver HM, Gibbs RS, Gray BM, Dillon HC. Risk factors for perinatal group B streptococcal disease after amniotic fluid colonization. Am J Obstet Gynecol 1990;163:19-25.
42. Lloyd DJ, Belgaumker TK, Scott KE, Aterman R, Krause VW. Prevention of group B β-hemolytic streptococcal septicemia in low-birth-weight neonates by penicillin administered within 2 hours of birth. Lancet 1979;1:713-5.
43. Pyati SP, Pildes RS, Jacobs NM, Ramamurthy RS, Yeh TF, Raval DS, et al. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med 1983;308:1383-9.
44. Siegel JD, McCracken GHJ, Threlkeld N, DePasse BM, Rodenfeld CR. Single-dose penicillin prophylaxis for neonatal group B streptococcal disease. Lancet 1982;1:1426-30.
45. Siegel JD, Cushion NB. Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth. Obstet Gynecol 1996;87:692-8.
46. Friedman CA, Wender DF, Temple DM, Rawson JE. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn. Am J Perinatol 1990;7:1-4.
47. Edwards MS. Group B streptococcal infections. Pediatr Infect Dis J 1990;9:778-81.
48. Hill HR, Gonzales A, Knappe WA, Fischer GW, Kelsey DK, Raff HV. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci. J Infect Dis 1991;163: 792-8.
49. Schreiber JR, Berger M. Intravenous immune globulin therapy for sepsis in premature infants. J Pediatr 1992;121:401-4.
50. Coleman RT, Sherer DM, Maniscalco WM. Prevention of neonatal group B streptococcal infections: advances in maternal vaccine development. Obstet Gynecol 1992;80:301-9.
51. Weisman LE. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr 1992;121:428-33.
52. Baker CJ, Noya FJ. Potential use of intravenous immune globulin for group B streptococcal infection. Rev Infect Dis 1990;12(suppl 4):S476-82.
53. Givner LB, Baker CJ. Pooled human IgG hyperimmune for type III group B streptococci: evaluation against multiple strains in vitro and in experimental disease. J Infect Dis 1991;163:1141-5.
54. Weisman LE, Anthony BF, Hemming VG, Fischer GW. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. J Pediatr 1993;122:929-37.
55. Baker CJ. Vaccine prevention of group B streptococcal disease. Pediatr Ann 1993;22:711-4.
56. Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis 1985;7:458-67.
57. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988;319:1180-5.
58. Baker CJ, Rench MA, Kasper DL. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med 1990;322:1857-60.
59. Wessels MR, Paoletti LC, Kasper DL, DiFabio JL, Michon F, Holme K, et al. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest 1990;86: 1428-33.
60. Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996;98: 2308-14.
61. Weinberg GA, Granoff DM. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. J Pediatr 1988;113:621-31.
62. Stalhammer-Carlemalm M, Stenberg L, Lindahl G. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 1993;177:1593-603.
63. Raff HV, Siscoe PJ, Wolff EA, Maloney G, Shuford W. Human monoclonal antibodies to group B Streptococcus. Reactivity and in vivo protection against multiple serotypes. J Exp Med 1988;168:905-17.
64. Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis. JAMA 1993;270:1442-8.
65. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1996;45:1-24.
66. American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococccal disease in newborns. ACOG Comm Opin 1996;173:1-8.
67. Committee on Infectious Diseases and Committee on Fetus and Newborn, American Academy of Pediatrics. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96.
68. Committee on Issues and Priorities for New Vaccine Development, Instititute of Medicine. Prospects for immunizing against Streptococcus group B. In: New vaccine development: establishing priorities. Vol. 1. Diseases of importance in the United States. Washington, DC: National Academy Press, 1985:424-39.